Filing Details
- Accession Number:
- 0001387131-20-007758
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-24 09:00:11
- Reporting Period:
- 2020-08-20
- Accepted Time:
- 2020-08-24 09:00:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | Pharmaceutical Preparations (2834) | 261434750 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1716713 | Smith Margaret Bell | C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Ave., Suite 306 New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Acquisiton | 2020-08-20 | 5,391 | $0.93 | 5,391 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9262 to $0.9273, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein.